Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis–related fatigue.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 942, doi. 10.1177/1352458520936226
- By:
- Publication type:
- Article